financetom
Business
financetom
/
Business
/
Nordstrom tops quarterly revenue estimates as newer products boost demand
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Nordstrom tops quarterly revenue estimates as newer products boost demand
May 30, 2024 2:03 PM

May 30 (Reuters) - Nordstrom ( JWN ) beat Wall Street

expectations for first-quarter revenue on Thursday, as the

department store chain's efforts to stock up shelves with

fresher clothing and footwear offerings helped drive demand.

The retailer in order to address its merchandising issues

has made attempts to bring in more in-demand clothing at its

namesake brand by offering tailored classics along with

minimalist pieces like oversized blazers, tailored pants,

cropped jackets and dresses.

Sales at the company's eponymous label recorded a 0.6% rise.

Discount banner Rack's sales rose 13.8% as Nordstrom ( JWN ) pushes

ahead with plans of opening more of its stores in a bid to

attract lower-income consumers.

During the quarter, Nordstrom ( JWN ) also put up numerous

shop-in-shop and online offerings of Liberty London and SKIMS by

partnering with them to feature their products.

Nordstrom ( JWN ) has also been opening shelf spaces for brands like

Birkenstock and Prada Beauty to drive customer traffic by

enhancing the products its stores offer as these continue to be

consumer favorites.

The company's better-than-feared sales result is in contrast

with peers Macy's and Kohl's, which are finding it

difficult to attract customers and are fixing merchandising

issues at their stores as well.

However, Nordstrom ( JWN ) reaffirmed its 2024 comparable sales

forecast of a 1% drop to a 2% rise and annual profit per share

of $1.65 to $2.05.

The department store operator's first-quarter total revenue

rose 4.8% to $3.34 billion, compared to LSEG expectations of a

0.6% rise to $3.20 billion.

The company's quarterly net loss narrowed to $39 million, or

24 cents per share, from $205 million, or $1.27 per share, a

year ago.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Eton Pharmaceuticals Submits New Drug Application to FDA For ET-400
Eton Pharmaceuticals Submits New Drug Application to FDA For ET-400
Apr 30, 2024
11:21 AM EDT, 04/30/2024 (MT Newswires) -- Eton Pharmaceuticals ( ETON ) said Tuesday it submitted a new drug application to the US Food and Drug Administration seeking approval for ET-400, the company's patented formulation of hydrocortisone oral solution. The drug maker said it expects a 10-month review from the FDA, with potential approval and launch in Q1 of 2025....
Ecolab Gains After Beating Q1 Sales Expectations And Raising FY24 Outlook; Divests Surgical Segment For $950M
Ecolab Gains After Beating Q1 Sales Expectations And Raising FY24 Outlook; Divests Surgical Segment For $950M
Apr 30, 2024
Ecolab Inc. ( ECL ) shares are gaining on Tuesday after the company reported first-quarter results. The company reported quarterly adjusted earnings per share of $1.34, which is in line with the street view.  Quarterly sales of $3.752 billion beat the analyst consensus of $3.748 billion. Sales gained 5% year over year, led by strong growth in the Institutional & Specialty and Pest Elimination segments and modest Industrial segment growth....
Pfizer, Genmab Say FDA Approves Tivak to Treat Cervical Cancer
Pfizer, Genmab Say FDA Approves Tivak to Treat Cervical Cancer
Apr 30, 2024
11:16 AM EDT, 04/30/2024 (MT Newswires) -- Pfizer ( PFE ) and Genmab ( GMAB ) said Monday that the US Food and Drug Administration approved a supplemental biologics license application for Tivak to treat patients with recurrent or metastatic cervical cancer with disease progression on or after chemotherapy. The approval comes after the application received a priority review designation...
Zuora to Acquire Event Metering, Rating Product Togai
Zuora to Acquire Event Metering, Rating Product Togai
Apr 30, 2024
11:19 AM EDT, 04/30/2024 (MT Newswires) -- Zuora ( ZUO ) said Tuesday it is acquiring Togai, a product for metering and rating raw events. Togai will become part of Zuora's ( ZUO ) offerings on closing and its founders Abhishek Rajagopal, Aravind Sriraman and Tholkappiyan Velavan will also join Zuora ( ZUO ), according to the company. Zuora (...
Copyright 2023-2026 - www.financetom.com All Rights Reserved